Alanine scanning of VIP -: Structure-function relationship for binding to human recombinant VPAC1 receptor

被引:0
|
作者
Nicole, P
Rouyer-Fessard, C
Couvineau, A
Drouot, C
Fulcrand, P
Martinez, J
Laburthe, M [1 ]
机构
[1] Fac Med Bichat, INSERM, U410, F-75018 Paris, France
[2] CNRS, URM5810, F-34094 Montpellier, France
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:352 / 356
页数:5
相关论文
共 50 条
  • [31] VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model
    Storka, Angela
    Burian, Bernhard
    Fuehrlinger, Gerhard
    Clive, Breanna
    Sun, Terri
    Crevenna, Richard
    Gsur, Andrea
    Mosgoeller, Wilhelm
    Wolzt, Michael
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [32] The N-Terminal Parts of VIP and Antagonist PG97-269 Physically Interact with Different Regions of the Human VPAC1 Receptor
    Ceraudo, Emilie
    Tan, Yossan-Var
    Nicole, Pascal
    Couvineau, Alain
    Laburthe, Marc
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 36 (1-3) : 245 - 248
  • [33] The N-Terminal Parts of VIP and Antagonist PG97–269 Physically Interact with Different Regions of the Human VPAC1 Receptor
    Emilie Ceraudo
    Yossan-Var Tan
    Pascal Nicole
    Alain Couvineau
    Marc Laburthe
    Journal of Molecular Neuroscience, 2008, 36 : 245 - 248
  • [34] The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor
    Ceraudo, Emilie
    Tan, Yossan-Var
    Nicole, Pascal
    Couvineau, Alain
    Laburthe, Marc
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2007, 33 (03) : 345 - 346
  • [35] VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model
    Angela Storka
    Bernhard Burian
    Gerhard Führlinger
    Breanna Clive
    Terri Sun
    Richard Crevenna
    Andrea Gsur
    Wilhelm Mosgöller
    Michael Wolzt
    Journal of Translational Medicine, 11
  • [36] Structure and structure-function relationships of human recombinant FSH
    Combarnous, Y
    M S-MEDECINE SCIENCES, 1999, 15 (02): : 167 - 174
  • [37] Site-directed mutagenesis of vasoactive intestinal peptide (VIP) receptor subtypes VIP1 and VIP2. Difference in their structure-function relationship.
    Nicole, P
    Du, K
    Couvineau, A
    Laburthe, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (05): : 365 - 369
  • [38] Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation
    Juarranz, MG
    Van Rampelbergh, J
    Gourlet, P
    De Neef, P
    Cnudde, L
    Robberecht, P
    Waelbroeck, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (01): : 449 - 456
  • [39] Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation
    Langer, I
    Robberecht, P
    CELLULAR SIGNALLING, 2005, 17 (01) : 17 - 24
  • [40] Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP
    Tan, YV
    Couvineau, A
    Laburthe, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) : 38889 - 38894